Form 8-K - Current report:
SEC Accession No. 0001628908-23-000176
Filing Date
2023-11-03
Accepted
2023-11-03 08:55:52
Documents
16
Period of Report
2023-11-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 11.02.2023 8-K (K&S) evh-20231103.htm   iXBRL 8-K 33437
2 EX-5.1 exhibit51.htm EX-5.1 8375
3 EX-5.2 exhibit52.htm EX-5.2 8827
7 image_01.jpg GRAPHIC 45221
8 image_0a.jpg GRAPHIC 45221
  Complete submission text file 0001628908-23-000176.txt   313355

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evh-20231103.xsd EX-101.SCH 1916
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evh-20231103_lab.xml EX-101.LAB 25852
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evh-20231103_pre.xml EX-101.PRE 13592
10 EXTRACTED XBRL INSTANCE DOCUMENT evh-20231103_htm.xml XML 2940
Mailing Address 800 NORTH GLEBE RD, SUITE 500 ARLINGTON VA 22203
Business Address 800 NORTH GLEBE RD, SUITE 500 ARLINGTON VA 22203 571-389-6000
Evolent Health, Inc. (Filer) CIK: 0001628908 (see all company filings)

EIN.: 320454912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37415 | Film No.: 231374623
SIC: 8741 Services-Management Services